UBS Oncology Impact Fund L.P. Insider Trading $HARP Harpoon Therapeutics, Inc.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for UBS Oncology Impact Fund L.P..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of UBS Oncology Impact Fund L.P.. UBS Oncology Impact Fund L.P. is 10% Owner in Oncorus, Inc. ($ONCR) and 10% Owner in Harpoon Therapeutics, Inc. ($HARP) and 10% Owner in TCR2 THERAPEUTICS INC. ($TCRR) and 10% Owner in Cullinan Management, Inc. ($CGEM).
UBS Oncology Impact Fund L.P. in Harpoon Therapeutics, Inc.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of UBS Oncology Impact Fund L.P.: 10% Owner
Holdings: 1,525,165 shares
Latest Transaction: Feb 14 2019
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of UBS Oncology Impact Fund L.P. in Harpoon Therapeutics, Inc.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, CGEM, HARP, ONCR, TCRR
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 14 2019 | HARP | Harpoon Therapeuti ... | UBS Oncology Impact Fund L.P. | 10% Owner | Option Exercise | X | 0.05 | 50,838 | 2,501 | 0 | |
| Feb 14 2019 | HARP | Harpoon Therapeuti ... | UBS Oncology Impact Fund L.P. | 10% Owner | Option Exercise | X | 0.05 | 76,258 | 3,752 | 0 | |
| Feb 14 2019 | HARP | Harpoon Therapeuti ... | UBS Oncology Impact Fund L.P. | 10% Owner | Option Exercise | C | 0.00 | 417,853 | 0 | 0 | |
| Feb 14 2019 | HARP | Harpoon Therapeuti ... | UBS Oncology Impact Fund L.P. | 10% Owner | Option Exercise | C | 0.00 | 1,578,755 | 0 | 0 | |
| Feb 14 2019 | HARP | Harpoon Therapeuti ... | UBS Oncology Impact Fund L.P. | 10% Owner | Option Exercise | C | 0.00 | 1,525,165 | 0 | 0 | |
| Feb 14 2019 | HARP | Harpoon Therapeuti ... | UBS Oncology Impact Fund L.P. | 10% Owner | Buy | P | 14.00 | 250,000 | 3,500,000 | 3,898,422 | 3.6 M to 3.9 M (+6.85 %) |
| Feb 14 2019 | HARP | Harpoon Therapeuti ... | UBS Oncology Impact Fund L.P. | 10% Owner | Sell | S | 14.00 | 447 | 6,258 | 3,648,422 | 3.6 M to 3.6 M (-0.01 %) |
| Feb 14 2019 | HARP | Harpoon Therapeuti ... | UBS Oncology Impact Fund L.P. | 10% Owner | Buy | X | 0.05 | 127,096 | 6,253 | 3,648,869 | 3.5 M to 3.6 M (+3.61 %) |
| Feb 14 2019 | HARP | Harpoon Therapeuti ... | UBS Oncology Impact Fund L.P. | 10% Owner | Buy | C | 0.00 | 417,853 | 0 | 3,521,773 | 3.1 M to 3.5 M (+13.46 %) |
| Feb 14 2019 | HARP | Harpoon Therapeuti ... | UBS Oncology Impact Fund L.P. | 10% Owner | Buy | C | 0.00 | 1,578,755 | 0 | 3,103,920 | 1.5 M to 3.1 M (+103.51 %) |
| Feb 14 2019 | HARP | Harpoon Therapeuti ... | UBS Oncology Impact Fund L.P. | 10% Owner | Buy | C | 0.00 | 1,525,165 | 0 | 1,525,165 | 0 to 1.5 M |
Page: 1